N/A
Completed N=353
Smart Linkage-to-HIV Care Via a Smartphone App
HIV · Viral Load · Patient Compliance · Antiretroviral Therapy
Source: ClinicalTrials.gov NCT02756949 ↗
Enrolled (actual)
353
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Linkage to HIV Care (Indicated by a HIV-related Laboratory Blood Test Within 8 Months) — 88; 74; 93; 90 Participants
Summary
This randomized controlled trial evaluates the provision of individual patient laboratory results to newly diagnosed HIV positive smartphone users through a secure application (app) as a method to get them linked to and retained in care, and engage with educational materials purposefully developed to explain their results. Message prompts will also be used to alert patients that their results are ready and provide information on how to link to care, and assistance to re-link to care if they fall out of the health system for any reason. Prompts will be sent to patients to remind health care workers if they are due for repeat laboratory monitoring. The primary endpoint is linkage to care (a HIV-related laboratory test) at 6 months. The control group received standard of care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Linkage to HIV Care (Indicated by a HIV-related Laboratory Blood Test Within 8 Months) |
88; 74; 93; 90 | — |
| SECONDARY Linkage to HIV Care Among Young People (Indicated by a HIV-related Laboratory Blood Test Within 8 Months) |
44; 22; 39; 47 | — |
Eligibility Criteria
Inclusion Criteria
- Newly diagnosed HIV positive clients presenting at selected public health facilities, irrespective of CD4 count
- Access to an Android smartphone with data
- Willing to pay the (very small) cost to access their laboratory result
- Age - 18 years and older
- Proof of ID/passport/refugee number (for identification/security, and to confirm the single patient identifier)
- Can read English or Zulu
- Ability and willingness to sign informed consent
Exclusion Criteria
- Clients presenting for antenatal care services, as these women will be enrolled in the national MomConnect program
- Refusal to participate
Data sourced from ClinicalTrials.gov (NCT02756949). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.